期刊文献+

不同促排卵方案在体外受精-胚胎移植中应用的比较 被引量:12

Comparison of Different Ovarian Hyperstimulation Protocol in in vitro Fertilization-Embryo Transfer
原文传递
导出
摘要 目的:比较不同促排卵方案在体外受精-胚胎移植中应用的有效性,为促排卵方案临床合理应用提供依据。方法:2013年1月至2015年6月在我院生殖医学中心接受长方案(599个周期)、短方案(202个周期)及拮抗剂方案(123个周期)治疗的患者,观察其胚胎发育、临床妊娠结局及并发症情况等。结果:长方案组与拮抗剂组的平均年龄[(32.75±4.45)和(33.97±5.09)岁]及基础FSH[(7.23±2.32)和(7.97±3.57)IU/L]均显著低于短方案组[(36.04±4.87)岁;(10.07±5.37)IU/L]。长方案组的平均获卵数最高(13.27±6.69),短方案组最低(7.72±5.23),各组间差异显著。3组的平均促性腺激素释放激素激动剂(GnRH-a)用量无显著差异[(2 587±919)和(2 652±1 131),(2 498±1 111)IU],但短方案组和拮抗剂组的平均Gn天数[(10.01±2.19)和(9.88±2.06)d]及卵巢过度刺激综合征(OHSS)发生率(1.49%,0)均显著低于长方案组[(10.79±1.62)d;6.68%]。胚胎发育方面,3组的受精率、卵裂率、两原核(2PN)受精率、2PN卵裂率和异常受精率均无显著差异。长方案组和拮抗剂组的可利用胚胎率(47.56%和48.75%)显著低于短方案组(56.77%)。妊娠结局方面,3组方案的临床妊娠率(44.03%,42.86%,39.29%)、生化妊娠率(12.50%,11.43%,3.57%)和胚胎种植率(28.46%,27.66%,25.81%)均无统计学差异(P>0.05)。结论:长方案、短方案和拮抗剂方案具有相似的妊娠结局,但后两者的OHSS发生率显著低于长方案。 Objective: To explore the effectiveness of different ovarian stimulation protocol in in vitro fertilization (IVF) outcome. Methods: The data from 924 IVF cycles, including long GnRH ago- nist (GnRH-a) protocol (599 cycles), short GnRH agonist protocol (202 cycles) and GnRH an- tagonist (GnRH-ant) protocol (123 cycles) were collected in Beijing Chaoyang Hospital from Jan- uary 2013 to June 2015. The general information, embryonic development and clinical outcomes were compared among these three groups. Results: The average age and basic FSH level in short GnRH-a group,(36.04±4.87) years and (10. 07±5. 37) IU/L, were significantly higher than those of long GnRH-agroup and GnRH-ant group, (32.75±4.45) and (33.97±5.09) years;(7.23±2.32) and (7.97±3.57) IU/L, respectively. Dosage of Gn were similar in three groups as (2 587±919), (2 652±1 131) and (2 498±1 111) IU, respectively, but differences in the du- ration of stimulation and OHSS rate were significant between long GnRH-a group as [10. 79±1.62) d, 6.68%] and the other two groups as (10.79±1. 62) vs (10. 01±2.19), (9. 882±2.06) d and 6. 68% vs 1. 49%, 0, respectively. The numbers of oocytes were obviously different in three groups as (13.27±6.69), (7. 72±5.23) , (10.35±6.38), P〈0.05. Available embryo rate was significantly higher in short GnRH-a group (56. 77%) compared with the other two groups (47. 56% and 48. 75%). There were no difference in clinical pregnancy rate (44.03%, 42.86% and 39.29%), biochemical pregnancy rate (12.50%, 11.43%, and 3.57%) and implantation rate (28.46%, 27. 66%, and 25.81%) in three groups. Conclusion. Long GnRH-a protocol, short Gn- RH-a protocol and GnRH-ant protocol have similar pregnancy outcomes, hut short GnRH-a protocol and GnRH-ant protocol have lower OHSS rate as compared with long GnRH-a protocol.
出处 《武汉大学学报(医学版)》 CAS 2016年第2期254-257,共4页 Medical Journal of Wuhan University
基金 国家自然科学基金面上项目(编号:81270753 81471511) 北京市高层次卫生人才培养计划(编号:2013-3-021) 首都医科大学附属北京朝阳医院青年科学基金项目(编号:YQ2014-12)
关键词 体外受精-胚胎移植 促排卵方案 GNRH拮抗剂 GNRH激动剂 in vitro Fertilization-Embryo Transfer Ovarian Stimulation Protocol GnRHAntagonist GnRH Agonist
  • 相关文献

参考文献10

  • 1Borm G,Mannaerts B.Treatment with the gonadotropin-releasing hormone antagonist ganirelixin women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective,safe and convenient:results of a controlled,randomized,multicentre trial[J].Hum Reprod,2000,15(7):1 490-1 498.
  • 2Kurzawa R,Ciepiela P,Baczkowski T,et al.Comparison of embryological and clinical outcome in GnRH antagonist vs GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients:aprospective randomized study[J].J Assist Reprod Genet,2008,25(8):365-374.
  • 3Nikolettos N,Al-Hasani S,Felberbaum R,et al.Gonadotropin-releasing hormone antagonist protocol:a novel method of ovarian stimulation in poor responders[J].Eur J Obstet Gynecol Reprod Bio1,2001,97(2):202-207.
  • 4Orvieto R,Meltzer S,Rabinson J,et al.GnRH agonist versus GnRH antagonist in ovarian stimulation:the role of endometrial receptivity[J].Fertil Steril,2008,90(4):1 294-1 296.
  • 5Hemandez ER.Embryo implantation and GnRH antagonists[J].Hum Reprod,2000,15(6):1 211-1 216.
  • 6Luna M,Vela G,McDonald CA,et al.Results with GnRH antagonist protocols are equivalent to GnRH agonist protocols in comparable patient populations[J].J Reprod Med,2012,57(3-4):123-128.
  • 7Tarlatzis BC,Fauser BC,Kolibianakis EM,et al.GnRH antagonists in ovarian stimulation for IVF[J].Hum Reprod,2006,12(4):333-340.
  • 8Cota AMM,Oliveira JBA,Petersen CG,et al.GnRH agonist versus GnRH antagonist in assisted reproduction cycles:oocyte morphology[J].Reprod Biol Endocrino,2012,10:33.
  • 9Mustafa K,Turgut A,Turhan A,et al.Comparison of GnRH agonist and antagonist protocols in normoresponder patients who had IVF-ICSI[J].Arch Gynecol Obstet,2013,288(6):1 413-1 416.
  • 10Takahashi K,Mukaida T,Tomiyama T,et al.GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol[J].J Assist Reprod Genet,2004,21(9):317-322.

同被引文献89

引证文献12

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部